Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-07-17The HIV Second-line Therapy AntiRetroviral Study in Patients Who Failed NNRTI-based Regimens
-
CLINICAL_TRIALS study record update · 2020-07-17A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects
-
CLINICAL_TRIALS study record update · 2020-07-17The Pharmacokinetics of Atazanavir / Ritonavir 200/100 OD Versus 300/100 mg OD in Combination With 2 NRTIs in HIV Pre-treated Patients
-
CLINICAL_TRIALS study record update · 2020-07-17Impact of Pharmacogenomics on Antiretroviral Drugs (Atazanavir and Efavirenz) Concentration and Treatment Response in HIV-infected Adults Study-team
-
CLINICAL_TRIALS study record update · 2020-07-17A 48 Week, Randomized, Open-label, 2 Arm Study to Compare the Efficacy, Safety and Tolerability of HAART Containing Nevirapine 400mg/Day Versus Nevirapine 600 mg/Day in HIV-1 Infected Patients Started at 2-6 Weeks After Initiating Rifampin Containing Antituberculous Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-07-17Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2020-07-17Comparing the Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens for Children Failing Non Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Treatment
-
CLINICAL_TRIALS study record update · 2020-07-17Pharmacokinetics and Efficacy of Low- or Standard-dose of Lopinavir/Ritonavir (Kaletra®) in PI-naïve HIV-1 Infected Children
-
CLINICAL_TRIALS study record update · 2020-07-17The Pharmacokinetics and Safety of Generic Lopinavir/Ritonavir (200/50 mg Tablets) 400/100 mg q12h in Thai HIV-infected Pregnant Women
-
CLINICAL_TRIALS study record update · 2020-07-17Prevalence and Risk Factors of HIV-associated Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1 Infected Thai Individuals With Undetectable Viral Load in the HAART Era.
-
CLINICAL_TRIALS study record update · 2020-07-17The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
-
CLINICAL_TRIALS study record update · 2020-07-17Immunogenicity and Safety of Intradermal Compare to Intramuscular Hepatitis B Vaccination in HIV Children
-
CLINICAL_TRIALS study record update · 2020-07-17Clinical, Immunologic and Virological Outcomes of Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs
-
CLINICAL_TRIALS study record update · 2020-07-17The Pharmacokinetics and Safety of Ritonavir-boosted Indinavir 600/100mg Bid Combined With NRTIs in ARV naïve HIV/TB Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
-
CLINICAL_TRIALS study record update · 2020-07-17Pharmacokinetics of Low Dose Raltegravir
-
CLINICAL_TRIALS study record update · 2020-07-17A Pilot Study of the Pharmacokinetics and Safety of Lopinavir/Ritonavir 400/100mg Bid Versus Lopinavir/Ritonavir 600/150 mg BID Combined With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV/TB Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
-
CLINICAL_TRIALS study record update · 2020-07-17A Phase I Trial to Evaluate the Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Neonates at Risk of Acquiring HIV-1 Infection
-
CLINICAL_TRIALS study record update · 2020-07-16Trial of Vitamins in HIV Progression and Transmission (A Trial of Vitamins and HAART in HIV Disease Progression)
-
CLINICAL_TRIALS study record update · 2020-07-14A Phase I, Open-label, Single-dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dolutegravir + Rilpivirine (JULUCA™) 50 mg/25 mg Tablets in Healthy Participants of Japanese Descent
-
CLINICAL_TRIALS study record update · 2020-07-14Piloting At-birth Point of Care HIV Testing Strategies in Kenya
-
CLINICAL_TRIALS study record update · 2020-07-14Pregnancy in Women With HIV Infection: a Multicenter Cohort in Spain
-
CLINICAL_TRIALS study record update · 2020-07-08Reaching Black/African American and Hispanic/Latino MSM Through Social Media About Treatment as Prevention and Pre-Exposure Prophylaxis
-
CLINICAL_TRIALS study record update · 2020-07-07Nucleoside-Sparing Combination Therapy With Lopinavir/Ritonavir (LPV/r) + Raltegravir (RAL) vs. Efavirenz (EFV) + Tenofovir Disoproxil Fumarate + Emtricitabine (TDF/FTC) in Antiretroviral-Naïve Patients
-
CLINICAL_TRIALS study record update · 2020-07-01Treating HIV-infected Elite Controllers as a Model of HIV Remission
-
CLINICAL_TRIALS study record update · 2020-06-22A Phase 1, Multicompartmental Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers